Navigation Links
Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
Date:10/25/2009

s, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the timing, success and cost of Arena's lorcaserin program and other of its research and development programs; results of clinical trials or preclinical studies may not be predictive of future results; clinical trials and studies may not proceed at the time or in the manner Arena expects or at all; Arena's ability to partner or commercialize lorcaserin or other of its compounds or programs; the timing and ability of Arena to receive regulatory approval for its drug candidates; Arena's ability to obtain additional funds; Arena's ability to obtain and defend its patents; and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

    Contact: Arena Pharmaceuticals, Inc.     Media Contact: Russo Partners

    Jack Lief                                David Schull, President
    President and CEO                        david.schull@russopartnersllc.com
                                             858.717.2310
    Cindy McGee
    Manager, IR and Corporate Communications Anthony J. Russo, Ph.D., CEO
    '/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
2. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
3. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
4. Nutrition model stresses positive experience of eating
5. Ultrasound plus mammography finds more cancers, but increases false positives
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
8. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
9. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
10. A low prevalence of H pylori in HIV-positive patients
11. Drug Company-Funded Asthma Drug Studies More Positive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 06, 2015 Edvance360 LMS-SN ... announced it won the Software & Information Industry ... in the "Best Postsecondary Learning Management Solution" category. ... has been finalists for this award seven years running, ... stands out in the industry. , "The honor ...
(Date:5/6/2015)... 2015 A quality built chicken coop condo with ... practical way to raise chickens on a pasture. By installing ... it will have a chicken tractor that stands up to being ... years, as it is able to flex to uneven ground without ... the land are fertilized, and it will help provide the chickens ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Chesapeake ... the state of Virginia to acquire Intuitive Surgical, ... robot. The system upgrade includes enhanced surgical technique ... invasive procedures across a wide spectrum of specialties. ... reduced pain and quicker recovery times. , “As ...
(Date:5/6/2015)... 2015 The Beryl Institute announces the ... Patient Experience Journal (PXJ), an international, open access, peer-reviewed ... and improving patient experience. The second volume of PXJ ... globally, helps align the voices engaged and provides the ... in association with The Beryl Institute, Volume 2, Issue ...
(Date:5/6/2015)... Colorado (PRWEB) May 06, 2015 Is ... success? , Next month the Centennial State will mark ... recreational cannabis sales to adults. And while Colorado’s legal ... growth during that time, it’s also facing some new ... state are currently facing shortages, especially in the wake ...
Breaking Medicine News(10 mins):Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3
... men who don,t need treatment , MONDAY, April 19 ... prostate cancer test can help improve predictions about which ... The basic test measures blood levels of prostate-specific androgen ... the standard PSA test cannot distinguish between cancers that ...
... malaria, a form of the disease thought to be ... that the parasite is actually two similar but distinct ... to research published in The Journal of Infectious ... Hygiene & Tropical Medicine, the Hospital for Tropical Diseases ...
... drug helps prevent noninvasive disease more and has fewer ... News) -- The latest results from a landmark, long-running ... breast cancer in postmenopausal women, although some differences are ... (Evista), originally an osteoporosis drug, was less effective at ...
... ... announces the release of their 2010 Spring All Occasions Greeting Cards Catalog. This year ... to you or to access the virtual edition, visit CardsDirect.com. , ... Plano, TX ((PRWEB) April 19, 2010 -- CardsDirect, ...
... the University of Alabama at Birmingham (UAB) Department of ... will help predict which patients are more likely to ... findings also shed light on the genetics that result ... Caucasians, the researchers said. In data presented April ...
... D.C. - The first lung cancer clinical trial to ... in tumor biopsies is a step toward personalized care ... study leaders reported today during the American Association for ... The University of Texas M. D. Anderson Cancer Center ...
Cached Medicine News:Health News:New Test May Predict Prostate Cancer's Aggressiveness 2Health News:New Test May Predict Prostate Cancer's Aggressiveness 3Health News:Raloxifene, Tamoxifen Both Guard Against Breast Cancer 2Health News:Raloxifene, Tamoxifen Both Guard Against Breast Cancer 3Health News:CardsDirect 2010 Spring All Occasions Greeting Cards Catalog Released 2Health News:CardsDirect 2010 Spring All Occasions Greeting Cards Catalog Released 3Health News:UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis 2Health News:BATTLE links potential biomarkers to drugs for lung cancer 2Health News:BATTLE links potential biomarkers to drugs for lung cancer 3Health News:BATTLE links potential biomarkers to drugs for lung cancer 4
(Date:5/6/2015)... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... 31, 2015.  The net loss and the loss from ... $13.0 million, respectively, compared to $10.7 million and $8.8 ... March 31, 2015, Alexza had consolidated cash, cash equivalents, ... "We continue to focus on ways in which ...
(Date:5/6/2015)... May 6, 2015 /CNW/ - Celebrities, bloggers and influencers across ... to spread the important message that melanoma prevention begins with ... Maria Sharapova , Hilary Duff , and parenting author ... out to their networks on Monday to share this poignant ... The David Cornfield Melanoma Fund (DCMF)-producers ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/2qs6vr/cannulas_market ... "Cannulas Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, ... (Plastic, Metal) & End Users (Hospitals, Ambulatory Surgical ... to their offering. The global cannulas ... of 5.6% from 2015 to 2020 to reach ...
Breaking Medicine Technology:Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10Celebrities Tweet Their Support of Melanoma Awareness Month and #newfamilyrule 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3
... Concert Medical, LLC today announced the launch of ... These guidewires are designed to address an extensive range of coronary ... clearance for the use and sale in the U.S. of the ... is located in Norwell, Mass. and manufactures all ...
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Nabumetone Tablets USP, 500 mg and 750 mg. The ... equivalent to Nabumetone Tablets, a treatment for osteoarthritis and ...
Cached Medicine Technology:Concert Medical Launches 'Conductor™' Family of Interventional Coronary Guidewires 2Concert Medical Launches 'Conductor™' Family of Interventional Coronary Guidewires 3Mylan Receives Approval for Nabumetone Tablets 2
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
MBP's 200 L large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
... an immunometric ('sandwich') EIA for the ... serum or plasma. LH in the ... anti-LH antibodies directed at different epitopes. ... particles and the other is labelled ...
Medicine Products: